Results 141 to 150 of about 25,624 (186)
Cyclooxygenase-2 selective inhibitors increase the risk of alveolar osteitis: A systematic review and meta-analysis. [PDF]
Med Oral Patol Oral Cir BucalIsiordia-Espinoza MA +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Allergy, 2002
. CELECOXIB, a cyclooxygenase-2 inhibitor (Celebrex, GD Searle and Co, Skokie, IL), is increasingly being used for the relief of pain and inflammation in patients with osteoarthritis and rheumatoid arthritis. Elsewhere we reported on two patients with a hypersensitivity reactions after ingestion of rice are scarce (4,5).
M, Grob, W J, Pichler, B, Wüthrich
openaire +2 more sources
. CELECOXIB, a cyclooxygenase-2 inhibitor (Celebrex, GD Searle and Co, Skokie, IL), is increasingly being used for the relief of pain and inflammation in patients with osteoarthritis and rheumatoid arthritis. Elsewhere we reported on two patients with a hypersensitivity reactions after ingestion of rice are scarce (4,5).
M, Grob, W J, Pichler, B, Wüthrich
openaire +2 more sources
Annals of Allergy, Asthma & Immunology, 2001
Adverse reactions such as urticaria, angioedema, asthma, and anaphylaxis are known to be associated with nonsteroidal anti-inflammatory agents (NSAIDs). Celecoxib (Pfizer/Searle, Caguas, PR) is a new NSAID that differs in structure and mechanism of action of other similar drugs of this class.Evaluation of a case of anaphylaxis to celecoxib (Celebrex ...
M B, Levy, J N, Fink
openaire +2 more sources
Adverse reactions such as urticaria, angioedema, asthma, and anaphylaxis are known to be associated with nonsteroidal anti-inflammatory agents (NSAIDs). Celecoxib (Pfizer/Searle, Caguas, PR) is a new NSAID that differs in structure and mechanism of action of other similar drugs of this class.Evaluation of a case of anaphylaxis to celecoxib (Celebrex ...
M B, Levy, J N, Fink
openaire +2 more sources
Anti-Cancer Drugs, 2012
Cox-2 inhibitors have been identified as promising candidates for cancer therapy. Several studies have recently proposed the use of celecoxib in long-term low-intensity chemotherapy protocols for recurrent tumors. However, drug-induced hypersensitivity reactions may force discontinuation of the medication and, thus, significantly complicate successful ...
Guido J, Burbach +2 more
openaire +2 more sources
Cox-2 inhibitors have been identified as promising candidates for cancer therapy. Several studies have recently proposed the use of celecoxib in long-term low-intensity chemotherapy protocols for recurrent tumors. However, drug-induced hypersensitivity reactions may force discontinuation of the medication and, thus, significantly complicate successful ...
Guido J, Burbach +2 more
openaire +2 more sources